Long-Term Proactive Management of Psoriasis Vulgaris With Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial. J of Skin 2020, 4 (5), s32. https://doi.org/10.25251/skin.4.supp.32.